Lorajmine
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| (17R,21β)-ajmalan-17,21-diol 17-chloroacetate OR (1R,9R,10S,13R,14R,16S,18S)-13-ethyl-8-methyl-14-hydroxy-8,15-diazahexacyclo [14.2.1.01,9.02,7.010,15.012,17]nonadeca-2(7),3,5-triene-18-yl chloroacetate |
|
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 47562-08-3 |
| ATC code | C01BA12 |
| ChemSpider | 16735878 |
| UNII | F96VX65849 |
| Chemical data | |
| Formula | C22H27ClN2O3 |
| Mol. mass | 402.914 g/mol |
|
|
|
|
| |
|
Lorajmine (17-monochloroacetylajmaline) is a drug that acts as a class Ia antiarrhythmic agent. It is an alkaloid from the roots of Rauwolfia serpentina.[1]
References[edit]
|
||||||||||||||||||||||||||||||||||||||||||||||||
| This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |